37
Participants
Start Date
June 8, 2023
Primary Completion Date
January 11, 2027
Study Completion Date
March 1, 2027
Microbial Transplantation Therapy
"Participants randomized to the MTT/antibiotic arm of PART A will be administered oral MTT capsules over the course of 28 days.~Participant enrolled on PART B will be administered oral MTT capsules over the course of 28 days."
Antibiotic
"Participants randomized to the MTT/antibiotic arm of PART A will receive oral antibiotics for 7 days prior to the MTT administration visit.~Participant enrolled on PART B will receive oral antibiotics for 7 days prior to the MTT administration visit."
Placebo (in place of MTT)
Participants randomized to the placebo arm of PART A will be administered oral placebo capsules in place of MTT over the course of 28 days.
Placebo (in place of antibiotics)
Participants randomized to the placebo arm of PART A will receive oral placebo in place of antibiotics for 7 days prior to the MTT administration visit.
Oral Immunotherapy (OIT)
Participant enrolled on PART B will be on maintenance peanut oral immunotherapy (OIT) for their clinical care.
RECRUITING
Boston Children's Hospital, Boston
University of Minnesota
OTHER
Rima Rachid
OTHER